1995: Opera CRO launched with three shareholders.
Eastern Europe: Opera was one of the first CROs in Eastern Europe, with an innovative approach to clinical research.
Tigermed Group: Opera partnered with Tigermed Group, the largest CRO in Asia and China, headquartered in Hong Kong.
2023: Tigermed fully acquired Opera CRO.
Tigermed EMEA: Opera CRO became Tigermed EMEA, an independent legal entity responsible for clinical research in Europe, Africa, and the Middle East.
Expansion: Tigermed SRL (formerly Opera CRO) has 15 subsidiaries in Europe and 1 subsidiary in South Africa.
Team and Mission: With over 200 professionals, Tigermed SRL continues to pursue excellence in the clinical research industry.

Tigermed EMEA

Org chart

Teams

Offices